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Problem Definition
Excisional biopsy is the gold standard for 
diagnosing lymphoma. In our previous analysis of 
457 biopsy samples performed at TJUH from 
2016-2019 (QR code), we confirmed that 
excisional biopsy of lymph nodes in patients with 
suspected lymphoma should remain
the standard of care. However, core
needle biopsies (CNBs) have been
ordered with increasing frequency
(19%-27.7%) even for lymph nodes
that can be surgically excised with ease- namely,
axilla (34.7%), inguinal (14.4%), supraclavicular 
(11.9%), and cervical (8.5%)- leading to repeat 
biopsies (diagnostic accuracy of excisional versus 
CNB is 96.8% versus 56.8%, respectively).
Aims For Improvement
The aim of this study is to increase the rate of 
excisional lymph node biopsies from 78% to 95% 
in patients presenting to the Center City campus 
with lymphadenopathy at easily accessible sites 
by September 2021.
Intervention
We have reviewed all lymph node biopsies 
performed at easily accessible sites at the Center 
City campus from January to December 2020, in 
order to identify change concepts for a PDSA cycle 
in the context of the most current practices. 
Measurements/Results
à75 total lymph nodes, with an excisional biopsy 
rate of 65%
àLymphoma was primary differential in 46% of 
CNBs performed
àProcess measures analyzed:
àDate of specimen collection
àPatient location (outpatient versus 
inpatient)
àMembers of care team involved and 
discussion of CNB versus excisional biopsy
Next Steps and 
Lessons Learned
Next steps include identification of key 
drivers to meet ultimate aim for 
improvement of increasing the rate of 
excisional lymph node biopsies to 95% 
of cases of suspected lymphoma by 
September 2021.
Data analysis thus far has revealed 
several opportunities for further 
intervention:
àConsistent involvement of both 
medical oncology and surgery when 
1) lymphoma is high on the 
differential in a patient presenting 
with lymphadenopathy and 2) when 
there is a discussion as to whether a 
CNB or excisional biopsy should be 
performed.
àDevelopment or improvement upon 
algorithms for patients presenting 
with lymphadenopathy.
We hope to conduct an 
interprofessional PDSA cycle based on 
an actionable intervention identified 
through our analyses and will repeat 
cycles pending our results.
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CNB in patients with suspected lymphoma
Inadequate tissue for accurate
pathologic diagnosis






CNBs at easily accessible sites, 
January-December 2020
Axilla
Inguinal
Supraclavicular
Cervical
Other
